BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21618960)

  • 21. Tumor lysis syndrome.
    Jeha S
    Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute tumour lysis syndrome.
    Chasty RC; Liu-Yin JA
    Br J Hosp Med; 1993 Apr 7-20; 49(7):488-92. PubMed ID: 8490688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome.
    Davidson MB; Thakkar S; Hix JK; Bhandarkar ND; Wong A; Schreiber MJ
    Am J Med; 2004 Apr; 116(8):546-54. PubMed ID: 15063817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The analysis of the risks for the development of tumour lysis syndrome in children.
    Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
    Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants.
    Froilán Torres C; Castro Carbajo P; Pajares Villarroya R; Plaza Santos R; Gómez Senent S; Martín Arranz MD; Adán Merino L; Martín Arranz E; Manceñido Marcos N; Peces R; Benito López D
    Rev Esp Enferm Dig; 2009 Apr; 101(4):288-94. PubMed ID: 19492906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor lysis syndrome.
    Rajendran A; Bansal D; Marwaha RK; Singhi SC
    Indian J Pediatr; 2013 Jan; 80(1):50-4. PubMed ID: 22752730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
    Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
    Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
    Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute tumor lysis syndrome: update on therapy].
    Jabbour E; Ribrag V
    Rev Med Interne; 2005 Jan; 26(1):27-32. PubMed ID: 15639323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor lysis syndrome in intensive therapy: diagnostic and therapeutic encare].
    Burghi G; Berrutti D; Manzanares W
    Med Intensiva; 2011 Apr; 35(3):170-8. PubMed ID: 21112673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and Treatment of Tumor Lysis Syndrome in the Era of Onco-Nephrology Progress.
    Matuszkiewicz-Rowinska J; Malyszko J
    Kidney Blood Press Res; 2020; 45(5):645-660. PubMed ID: 32998135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and management of tumor lysis syndrome in adults with malignancy.
    Sarno J
    J Adv Pract Oncol; 2013 Mar; 4(2):101-6. PubMed ID: 25031988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach.
    Hsu HH; Chan YL; Huang CC
    J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of tumor lysis syndrome in an outpatient setting.
    Mackiewicz T
    Clin J Oncol Nurs; 2012 Apr; 16(2):189-93. PubMed ID: 22459528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor lysis syndrome.
    Arrambide K; Toto RD
    Semin Nephrol; 1993 May; 13(3):273-80. PubMed ID: 8321927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving treatment for tumor lysis syndrome: strategies for every oncology nurse.
    ONS News; 2004; 19(9 Suppl):43-4. PubMed ID: 15478582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies.
    McBride A; Westervelt P
    J Hematol Oncol; 2012 Dec; 5():75. PubMed ID: 23237230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor Lysis Syndrome.
    Williams SM; Killeen AA
    Arch Pathol Lab Med; 2019 Mar; 143(3):386-393. PubMed ID: 30499695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review.
    Salter B; Burns I; Fuller K; Eshaghpour A; Lionel AC; Crowther M
    Eur J Haematol; 2022 Aug; 109(2):166-181. PubMed ID: 35531791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
    Alavi S; Arzanian MT; Abbasian MR; Ashena Z
    Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.